Search

Your search keyword '"Becker, Jürgen C."' showing total 911 results

Search Constraints

Start Over You searched for: Author "Becker, Jürgen C." Remove constraint Author: "Becker, Jürgen C." Language english Remove constraint Language: english
911 results on '"Becker, Jürgen C."'

Search Results

4. Early versus late response to PD-1-based immunotherapy in metastatic melanoma

8. Wnt/β-Catenin–Activated Nonpilomatrical Carcinoma of the Skin: A Case Series

12. Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM

13. Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

14. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases

15. Characterisation and outcome of RAC1 mutated melanoma

17. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

18. German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023

19. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial

20. Persister state-directed transitioning and vulnerability in melanoma

21. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.

22. Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation.

23. Single-cell RNA and T-cell receptor sequencing unveil mycosis fungoides heterogeneity and a possible gene signature.

24. Introducing MCC-PS: a novel prognostic score for Merkel cell carcinoma.

30. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma

32. Merkel cell polyomavirus pan‐T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1.

33. Incidence and Relative Survival of Patients with Merkel Cell Carcinoma in North Rhine-Westphalia, Germany, 2008–2021.

34. S1‐Guideline Sebaceous Carcinoma.

35. A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality.

36. Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update.

41. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

44. SATB1 in Malignant T Cells

Catalog

Books, media, physical & digital resources